Cochlear | COH - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Ansell USD 4.84B 1.48B 2026-08
Avita Medical AUD 105.47M 35.32M 2025-12
Cochlear AUD 7.9B 9.15B 2026-08
CSL USD 60.19B 4.3B 2026-08
Fisher Paykel Healthcare NZD 21.96B 201.12M 2026-06
Integral Diagnostics AUD 1.08B 457.31M 2024-12
Mayne Pharma AUD 252.67M 153.55M 2025-12
Mesoblast USD 2.33B 936.82M 2025-12
Monash IVF AUD 266.9M 19.48M 2026-08
Nanosonics AUD 963.21M 241.07M 2026-08
Polynovo AUD 849.74M 24.18M 2025-12
Ramsay Health Care AUD 10.02B 2.09B 2026-08
Regis Healthcare AUD 1.83B 271.12M 2026-08
ResMed USD 47.56B 4.96B 2026-03
Sigma Healthcare AUD 2.9B 1.78B 2026-07
Somnomed AUD 79.04M 27.72M 2023-06
Sonic Healthcare AUD 11.17B 1.7B 2025-12
Telix Pharmaceuticals AUD 5.07B 5.81B 2025-12